Vimarsana
Biggest News Aggregation in the World

Market Offering Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Market Offering Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Market Offering Program Today - Breaking & Trending Today

Star Bulk Carriers Corp. Reports Net Profit of $43.7 Million for the Third Quarter of 2023, and Declares Quarterly Dividend of $0.22 Per Share - Vimarsana News

Star Bulk Carriers Corp. Reports Net Profit of $43.7 Million for the Third Quarter of 2023, and Declares Quarterly Dividend of $0.22 Per Share

ATHENS, Greece, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the 'Company' or 'Star Bulk') (Nasdaq: SBLK), a global shipping comp...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript - Vimarsana News

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript - Vimarsana News

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript August 3, 2023 Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $0.12. Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. […]

Source: yahoo.com
Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program - Vimarsana News

Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program

18.02.2022 - Orphazyme A/SCompany announcementNo. 06/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 18, 2022 – Orphazyme A/S (ORPHA.CO (DK); ORPH (US)) (the “Company”), a late-stage biopharmaceutical company, announces ... Seite 1

Orphazyme establishes a U.S. At-the-Market Offering Program with Cowen - Vimarsana News

Orphazyme establishes a U.S. At-the-Market Offering Program with Cowen

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com